Pittenger & Anderson’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Pittenger & Anderson's EW Position: Q3 2026 in Review
Pittenger & Anderson increased its Edwards Lifesciences (EW) stake by 4.4% in Q3 2026, buying an estimated $23.3K and bringing the position to 6,196 shares worth $535K. The position accounts for 0.02% of the portfolio, ranked #198.
Pittenger & Anderson first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.1M in Q1 2026. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Pittenger & Anderson held 6,196 shares of Edwards Lifesciences worth $535K as of Q3 2026.
- Pittenger & Anderson bought 262 Edwards Lifesciences shares in Q3 2026, an estimated $23.3K.
- Edwards Lifesciences made up 0.02% of Pittenger & Anderson's portfolio in Q3 2026, its #198 holding.
- Pittenger & Anderson first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
- Pittenger & Anderson's Edwards Lifesciences position peaked at $2.1M in Q1 2026.
- 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.